Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The safety profile of Tirzepatide is generally favorable, with mild gastrointestinal side effects such as nausea and vomiting that typically resolve over time
31, 2025, Ousia voluntarily relinquished its regular pharmacy license, Florida records show
On average, patients may lose between 15% and 20% of their starting weight over 72 weeks when tirzepatide is used in combination with healthy lifestyle changes, such as improved diet and increased physical activity
However, Tirzepatide appears to provide fewer or less severe side effects
The METAOD006 (OPTIONS) oral Phase 2b trial measured weight at 12 and 24 weeks
Lead Researcher Spotlight Tamer Coskun, PhD Senior Research Advisor Eli Lilly and Company, Indianapolis, Indiana Dr
US$ 26.51
US$ 24.03
US$ 23.97
US$ 22.56
US$ 23.31
US$ 25.95
US$ 28.02
